Clinical Trials Logo
  1. Home
  2. Cystoid Macular Edema
  3. NCT04527523

Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping Only

Cystoid Macular Edema Clinical Trial

Official title:
Incidence of Post-operative Cystoid Macular Edema: A Prospective Study Comparing DMEK, DSEK, and DSO

Clinical Trial Summary

This study aims to evaluate and compare incidence of post-operative cystoid macular edema (CME) after Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet's Stripping Automated endothelial Keratoplasty (DSEK) and Descemet Stripping Only (DSO).

Clinical Trial Description

Patients that are undergoing any of these procedures will be asked if they are willing to have a baseline pre-operative Optical Coherence Tomography (OCT) scan completed within 4 weeks of surgery. Additional OCT scans will be collected during routine follow up care. It is hypothesized that the rates of CME will be lower with DSO compared to DMEK and DSEK. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04527523
Study type Observational
Source Wake Forest University Health Sciences
Contact
Status Terminated
Phase
Start date November 21, 2020
Completion date August 24, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT00508040 - Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a Phase 2
Terminated NCT00114062 - Study to Treat Uveitis Associated Macular Edema Phase 2
Completed NCT03025945 - Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo N/A
Completed NCT01978015 - Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG Phase 4
Recruiting NCT05158699 - Effectiveness of Periocular Drug Injection in CATaract Surgery Phase 3
Withdrawn NCT02598869 - Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema Phase 4
Completed NCT02294656 - Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide Phase 1
Not yet recruiting NCT04856670 - Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACS
Completed NCT02609165 - Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema Phase 2
Withdrawn NCT00438243 - Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema. Phase 2
Completed NCT00464581 - Lucentis for Treatment of Macular Edema N/A
Active, not recruiting NCT03465124 - Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery N/A
Recruiting NCT02486484 - Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection Phase 2
Completed NCT00790803 - Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema N/A
Recruiting NCT04225611 - Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema Phase 1/Phase 2
Completed NCT05832996 - Cool vs Room-temperature Artificial Tears Phase 4
Completed NCT05615805 - The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections N/A
Completed NCT00494494 - Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery Phase 4
Terminated NCT00346983 - Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics Phase 1/Phase 2
Terminated NCT00358423 - The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema Phase 1/Phase 2